# UK Hydrophobic Interaction Chromatography Market > UK Hydrophobic Interaction Chromatography Market Research Report: Size, Share, Trend Analysis By Product and Service (Resins, Columns, Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.67% - **2024:** $ 41.79 Million - **2025:** $ 45.41 Million - **2035:** $ 104.32 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/HC/54727-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-hydrophobic-interaction-chromatography-market-56493 --- ## Market Summary ## **UK Hydrophobic Interaction Chromatography Market Overview****:** As per MRFR analysis, the UK Hydrophobic Interaction Chromatography Market Size was estimated at 15.04 (USD Million) in 2023.The UK Hydrophobic Interaction Chromatography Market Industry is expected to grow from 16.2(USD Million) in 2024 to 55.3 (USD Million) by 2035. The UK Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 11.808% during the forecast period (2025 - 2035). ### **Key UK Hydrophobic Interaction Chromatography Market Trends Highlighted** The UK Hydrophobic Interaction Chromatography (HIC) market is growing rapidly due to important market drivers. In the UK, the development of biopharmaceuticals is accelerating the advancement of chromatographic techniques. This is largely because of the increased demand for monoclonal antibodies and vaccine-based therapeutics. With the evolution of the biopharmaceutical industry in the UK, there is a growing need for reliable separation methods, which increases the demand for HIC. Moreover, the UK market has a lot of untapped potential. The growth of personalized therapy offers a unique opportunity for HIC technology to address tailored requirements of different patient groups. There is still active investment in development and research by various UK universities. This also includes funding from pharmaceutical companies, which signifies a strong incentive framework that nurtures the innovation and adoption of HIC methodologies. These methodologies allow new techniques to be used for protein purification and enzyme isolation thereby increasing the use of HIC within the UK. Recently integrated advanced technologies and automation are becoming popular in Scotland. UK Labs are incorporating automated systems that increase efficiency and reproducibility. These systems are in alignment with global shifts towards improving precision in scientific research. There also global shifts regarding sustainability as well as eco-friendliness, especially in UK science, which embraces the use of greener solvents and materials for HIC. Looking at the combination of these trends, it paints a favorable picture for the hydrophobic interaction chromatography market in the UK out of responsive adaptability to evolving scientific needs and technologies. ## **UK Hydrophobic Interaction Chromatography Market Drivers** ### **Increasing Demand for Biopharmaceuticals in the UK** The UK Hydrophobic Interaction Chromatography Market Industry is witnessing significant growth, largely driven by the increasing demand for biopharmaceuticals. According to the UK Bioprocessing and Manufacturing Strategy, the biopharmaceutical sector is projected to grow by 30% over the next five years. Key players like GlaxoSmithKline and AstraZeneca are heavily investing in Research and Development activities to innovate and expand their biopharmaceutical portfolios.The rising prevalence of chronic diseases and the focus on personalized medicine are causing a surge in biopharmaceutical products, necessitating advanced purification techniques such as hydrophobic interaction chromatography. This trend is supported by the UK government encouraging bioprocessing innovations, thereby promoting the growth of the Hydrophobic Interaction Chromatography Market in the region. ### **Growth in Research and Development Activities** Another critical driver for the UK Hydrophobic Interaction Chromatography Market Industry is the increase in Research and Development activities across various sectors, especially in pharmaceutical and biotechnology industries. The UK government has allocated 9.5 billion for R&D initiatives in the year 2023, focusing on life sciences and biotechnology, which are crucial sectors for the use of hydrophobic interaction chromatography. Institutions such as the University of Cambridge and Imperial College London are conducting important research in this field and collaborating with industry leaders to enhance the efficiency of chromatographic techniques.This emphasis on R&D is likely to lead to innovative applications and further boost the market in the UK. ### **Regulatory Support for Advanced Therapeutics** Regulatory changes in the UK are also driving the growth of the Hydrophobic Interaction Chromatography Market Industry. The Medicines and Healthcare products Regulatory Agency (MHRA) has streamlined the approval process for new biotherapeutics and has endorsed the adoption of advanced purification technologies. With an emphasis on ensuring patient safety and efficacy, the MHRA is working with organizations to incentivize the development of new therapeutics, which rely on effective purification methods like hydrophobic interaction chromatography.Such supportive regulatory environments encourage firms to focus on the quality and effectiveness of their products, reflecting positively on market growth. ### **Surge in Continuous Manufacturing Practices** The shift towards continuous manufacturing practices is another significant driver for the UK Hydrophobic Interaction Chromatography Market Industry. The UK government has identified continuous manufacturing as a key to enhancing production efficiency and scalability in the pharmaceutical sector. Reports indicate that continuous processing can reduce manufacturing times by up to 30% and improve product quality. With industry leaders like Pfizer and Novartis investing in this technology, the adoption of hydrophobic interaction chromatography in continuous processes is likely to rise.This transition is aligned with the UK's broader goals of innovation in manufacturing and could substantially enhance the market potential for hydrophobic interaction chromatography. ## **UK Hydrophobic Interaction Chromatography Market Segment Insights****:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The UK Hydrophobic Interaction Chromatography Market encompasses various products and services essential for purification and separation processes in biopharmaceutical and biotechnology applications. The Product and Service segment is crucial for supporting research and development activities, particularly in the fields of protein purification and biomolecule characterization. Notably, the segment can be categorized into notable areas, including Resins, Columns, Services, and Others. Resins play an essential role in the chromatographic process by facilitating the separation of target molecules based on their hydrophobic interactions.  These materials are increasingly favored due to their customizable chemical properties, allowing for enhanced efficiency and specificity in the purification process. The Columns, designed to house these resins, are significant in shaping the overall performance of chromatographic systems, supporting various technologies and applications. Problems related to system compatibility and resin performance can lead to inefficiencies, highlighting the embodiment of robust and high-quality columns in market demand.In addition to Resins and Columns, Services, which include maintenance, consulting, and training, are fundamental in ensuring the effective operation of chromatography systems.  These services contribute to optimizing process performance and minimizing downtime, thereby enhancing laboratory productivity. Furthermore, the Other category encompasses various miscellaneous offerings, such as accessories and consumables, which inherently support the primary equipment and contribute to overall functionality.The increasing prevalence of biopharmaceutical development and the rising demand for monoclonal antibodies are notable drivers for the Hydrophobic Interaction Chromatography Market in the UK. As life sciences and biotechnology sectors continue to expand, the need for efficient purification techniques will drive growth within this segment. However, challenges such as fluctuating raw material prices and the high cost of advanced chromatography equipment may impact market dynamics. Overall, the Product and Service segment of the UK Hydrophobic Interaction Chromatography Market is pivotal to the industry's growth, underpinning the critical need for reliable and high-performance solutions that meet evolving industry demands. The interplay between advancing technology and growing market requirements is evidence of the importance of this market, which is set to witness continued expansion as it seeks to address the complexities of modern biopharmaceutical manufacturing and Research and Development efforts. ## **UK Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights****:** The UK Hydrophobic Interaction Chromatography Market is characterized by a diverse landscape of players offering a range of products and services aimed at various applications within the biotechnology and pharmaceutical industries. This market is primarily driven by the increasing demand for efficient purification and separation methods in the process of drug development and manufacturing. With the ongoing innovations in chromatography technologies, companies are striving to enhance their offerings and gain a competitive edge.  The presence of established players and emerging firms alike adds to the dynamic nature of this market, with ongoing challenges such as regulatory compliance, cost management, and technological advancements. As companies navigate these complexities, understanding the competitive dynamics and strengths within the sector is critical for sustained growth and market capture.Novasep has established a strong foothold in the UK Hydrophobic Interaction Chromatography Market, leveraging its extensive expertise in purification technologies. The company is recognized for its innovative solutions that cater to various biopharmaceutical applications, including monoclonal antibody production and protein purification. Novasep's commitment to research and development has led to a portfolio of advanced chromatography products designed to optimize separation processes, thereby enhancing overall productivity for its clients.  The company's established relationships within the UK biotech ecosystem, coupled with its technical support capabilities, further solidify its position as a trusted partner in the hydrophobic interaction chromatography space. This strong market presence is augmented by Novasep’s focus on providing scalable and customizable solutions tailored to meet the specific needs of its diverse clientele.Repligen Corporation has made significant strides in the UK Hydrophobic Interaction Chromatography Market with a portfolio that includes key products such as chromatography resins and systems designed for bioprocessing applications.  The company is positioned as a leader in enabling biomanufacturing processes with products that are recognized for their reliability and performance. Repligen has strategically enhanced its presence in the market through a series of mergers and acquisitions that have broadened its technological capabilities and product offerings. This approach not only expands Repligen's reach in the UK market but also strengthens its competitive advantage in providing efficient and cost-effective solutions for clients involved in biopharmaceutical production. The company's focus on high-quality, scalable products and continuous innovation underscores its commitment to meeting the evolving needs of the industry, establishing Repligen as a formidable player in the hydrophobic interaction chromatography sector within the UK. ### **Key Companies in the UK Hydrophobic Interaction Chromatography Market Include:** - Novasep - Repligen Corporation - Sartorius AG - BioRad Laboratories - Thermo Fisher Scientific - Kromatek - ACD/Labs - GE Healthcare - Merck KGaA - Takara Bio - Agilent Technologies - Dionex Corporation - Waters Corporation - LGC Limited - Pall Corporation ## **UK Hydrophobic Interaction Chromatography Market Industry Developments** The UK Hydrophobic Interaction Chromatography Market has seen notable developments recently, with companies like Novasep, Repligen Corporation, and Sartorius AG actively enhancing their product offerings to cater to growing demand in biopharmaceutical applications. In September 2023, BioRad Laboratories launched a new line of chromatography columns that improve separation efficiency, notably impacting market dynamics. Furthermore, Thermo Fisher Scientific is expanding its operations in the UK, aiming to strengthen its presence in life sciences and bioprocessing markets. In terms of mergers and acquisitions, GE Healthcare announced in August 2023 its acquisition of a leading chromatography technology firm, further solidifying its market position. Growth in market valuation is evident as significant investments in Research and Development from Merck KGaA and Waters Corporation are fueling innovation and competitiveness. Additionally, the UK government reported in March 2023 that advancements in biopharmaceutical manufacturing processes, which heavily rely on chromatography techniques, are projected to enhance the nation's healthcare system and boost economic growth. Overall, the UK Hydrophobic Interaction Chromatography Market is experiencing robust evolution driven by technological advancements and strategic business activities. ## **UK Hydrophobic Interaction Chromatography Market Segmentation Insights** ### **Hydrophobic Interaction Chromatography Market Product and Service****Outlook** - Resins - Columns - Services - Others ## Market Drivers ### Increasing Investment in Biotech The hydrophobic interaction-chromatography market is experiencing a surge in investment from biotechnology firms in the UK. This trend is driven by the growing need for advanced purification techniques in the production of biopharmaceuticals. In 2025, the UK biotechnology sector is projected to reach a valuation of £50 billion, indicating a robust environment for the hydrophobic interaction-chromatography market. As companies seek to enhance their production capabilities, the demand for effective separation methods, such as hydrophobic interaction chromatography, is likely to increase. This investment not only supports the development of innovative products but also fosters collaboration between research institutions and industry players, further propelling the market forward. ### Growing Demand for Quality Control The market is influenced by the growing demand for quality control in the UK pharmaceutical industry. With stringent regulations governing drug production, companies are increasingly adopting advanced purification techniques to ensure product safety and efficacy. The UK pharmaceutical market is expected to reach £40 billion by 2025, which may lead to heightened scrutiny of manufacturing processes. As a result, hydrophobic interaction chromatography is becoming a preferred method for quality assurance, as it effectively removes impurities and enhances product consistency. This trend indicates a strong potential for growth in the hydrophobic interaction-chromatography market as companies prioritize compliance with regulatory standards. ### Emerging Applications in Diagnostics There are emerging applications in the diagnostics sector within the UK. As the demand for rapid and accurate diagnostic tools increases, the need for effective separation techniques becomes critical. The UK diagnostics market is projected to reach £10 billion by 2025, which may drive the adoption of hydrophobic interaction chromatography for the purification of biomolecules. This technique offers advantages in terms of specificity and efficiency, making it suitable for various diagnostic applications. As healthcare providers seek to improve patient outcomes through advanced diagnostic methods, the hydrophobic interaction-chromatography market is likely to see increased utilization in this area. ### Rising Focus on Protein Therapeutics The market is benefiting from the increasing focus on protein therapeutics in the UK. As the healthcare sector shifts towards biologics, the demand for efficient purification methods becomes paramount. In 2025, the UK protein therapeutics market is expected to grow at a CAGR of 8%, which could significantly impact the hydrophobic interaction-chromatography market. This growth is attributed to the need for high-purity proteins in therapeutic applications, necessitating advanced chromatographic techniques. Consequently, manufacturers are likely to invest in hydrophobic interaction chromatography to meet the stringent quality requirements of protein-based drugs, thereby enhancing their market presence. ### Advancements in Chromatography Technology The market is poised for growth due to advancements in chromatography technology. Innovations in resin materials and column design are enhancing the efficiency and effectiveness of hydrophobic interaction chromatography. In 2025, the UK chromatography market is projected to grow by 6%, reflecting the increasing adoption of these advanced technologies. These improvements not only optimize separation processes but also reduce operational costs, making hydrophobic interaction chromatography more accessible to a wider range of applications. As research institutions and pharmaceutical companies continue to seek cutting-edge solutions, the hydrophobic interaction-chromatography market is likely to benefit from these technological advancements. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) is projected to grow at an 8.67% CAGR from 2025 to 2035, driven by increasing demand for biopharmaceuticals and advancements in chromatography technologies. **New opportunities:** - Development of high-throughput screening systems for rapid analysis. - Expansion of service contracts for chromatography equipment maintenance. - Integration of AI-driven analytics for process optimization. By 2035, the market is expected to achieve substantial growth, reflecting evolving industry needs. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Buffers (Fastest-Growing) In the UK hydrophobic interaction-chromatography market, the product and service segment comprises various components, including resins, columns, buffers, and other products and services. Resins currently hold the largest market share due to their critical role in enhancing separation efficiency and purity in bioprocessing applications. Columns follow, but the competition is intense, with several innovative offerings emerging. Conversely, buffers have been gaining traction, driven by their essential function in maintaining pH stability and enhancing separation performance, thus capturing a noteworthy share of the market. Growth trends in this segment are significantly influenced by the increasing demand for biopharmaceuticals and the need for efficient purification processes. The drive for higher yields and purity levels in biologics production is pushing innovation in resin chemistry and buffer formulation. Moreover, the rise in disposable chromatography products is streamlining processes, thus benefiting both the resins and buffers categories, ensuring they remain at the forefront of market growth. Resins (Dominant) vs. Other Products and Services (Emerging) Resins are the dominant segment in the product and service category of the UK hydrophobic interaction-chromatography market, recognized for their pivotal role in biopharmaceutical purification. Their ability to enhance separation quality and product yield is unmatched, making them essential for industry players. Conversely, other products and services, while currently emerging, include offerings like custom solutions and support services that complement the chromatography process. As companies strive for more personalized and efficient solutions, these offerings show promise in addressing unique customer needs. This evolving landscape reflects a shift towards integrated solutions, where resins are complemented by a diverse array of supportive products. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Vaccines (Fastest-Growing) In the UK hydrophobic interaction-chromatography market, the sample type segment is predominantly led by Monoclonal Antibodies, which hold the largest share among the various applications. This dominance is attributed to their extensive use in therapeutic developments and their consecutive significant investments in research and development. On the other hand, the Vaccines segment, while smaller in size comparatively, is gaining traction rapidly, driven by increased vaccination campaigns and the growing demand for innovative vaccine technologies. The growth trends in this segment reflect both emerging opportunities and solidifying existing markets. Monoclonal Antibodies continue to benefit from a well-established market presence, largely due to ongoing advancements in biotechnology. Conversely, the Vaccines segment is witnessing substantial growth propelled by a heightened focus on public health and global health initiatives. The increasing prevalence of infectious diseases and the need for preventive healthcare measures are expected to bolster the market expansion further. Monoclonal Antibodies (Dominant) vs. Vaccines (Emerging) Monoclonal Antibodies serve as the dominant player in the UK hydrophobic interaction-chromatography market owing to their pivotal role in the biopharmaceutical sector, particularly within oncology and autoimmune disease treatments. They are characterized by their specificity and efficacy, making them a preferred choice in therapeutic applications. In contrast, the Vaccines segment is emerging in response to the growing demand for preventative healthcare. Vaccines are positioned for rapid development, especially with ongoing research into new formulations and delivery methods. The increased investment in vaccine R&D aims to adapt to changing public health needs, setting a promising trajectory for this segment within the overall market. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations & Contract Manufacturing Organizations (Fastest-Growing) The UK hydrophobic interaction-chromatography market showcases a diverse range of end-users, with Pharmaceutical & Biopharmaceutical Companies holding the largest share. This segment benefits from an increased need for advanced purification processes for therapeutic proteins and monoclonal antibodies. Meanwhile, Contract Research Organizations & Contract Manufacturing Organizations are rapidly expanding due to the heightening demand for outsourced services, reflecting a significant shift in the market dynamics as companies look to improve efficiency and reduce operational costs. Growth trends indicate a robust commitment from Pharmaceutical & Biopharmaceutical Companies towards innovative research and development, leading to enhanced adoption of hydrophobic interaction-chromatography. Additionally, the rise of biologics and biosimilars significantly influences the market dynamics, referring to the constant need for efficient purification techniques. As the market evolves, the demand from Contract Research Organizations & Contract Manufacturing Organizations underscores a pivotal change, positioning them as key players in the segment. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations & Contract Manufacturing Organizations (Emerging) Pharmaceutical & Biopharmaceutical Companies dominate the UK hydrophobic interaction-chromatography market due to their extensive utilization of advanced chromatography techniques for drug development and production. This segment is characterized by its heavy investment in R&D, leading to innovations in biologics, which require reliable purification methodologies. Conversely, Contract Research Organizations & Contract Manufacturing Organizations are emerging as vital contributors to the market, offering outsourced chromatography services. They play a crucial role for smaller biotech firms that may lack in-house capabilities, effectively bridging the gap in expertise and operational efficiency. This shifting landscape highlights the collaborative nature of the market, where both segments increasingly rely on one another to drive advancements in biotherapeutic development. ## Competitive Benchmarking The hydrophobic interaction-chromatography market exhibits a dynamic competitive landscape, characterized by a blend of innovation and strategic positioning among key players. Companies such as GE Healthcare (US), Thermo Fisher Scientific (US), and Merck KGaA (DE) are at the forefront, leveraging their extensive portfolios and technological advancements to capture market share. GE Healthcare (US) emphasizes innovation in bioprocessing solutions, while Thermo Fisher Scientific (US) focuses on expanding its product offerings through strategic acquisitions and partnerships. Merck KGaA (DE) appears to be enhancing its operational capabilities by investing in digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological advancements and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market structure is moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like Agilent Technologies (US) and Bio-Rad Laboratories (US) is notable, as they contribute to a competitive atmosphere that encourages innovation and collaboration. In October Agilent Technologies (US) announced the launch of a new line of hydrophobic interaction chromatography columns designed to improve protein purification efficiency. This strategic move is significant as it not only enhances Agilent's product portfolio but also positions the company as a leader in addressing the growing demand for high-performance chromatography solutions. The introduction of these columns is likely to attract a broader customer base, particularly in the biopharmaceutical sector, where efficiency and yield are paramount. In September Bio-Rad Laboratories (US) expanded its collaboration with leading academic institutions to develop advanced chromatography techniques. This partnership is indicative of Bio-Rad's commitment to innovation and research, suggesting that the company is keen on integrating cutting-edge technologies into its offerings. Such collaborations may enhance Bio-Rad's competitive edge by fostering the development of novel solutions that meet evolving market needs. In August Merck KGaA (DE) unveiled a new digital platform aimed at streamlining the chromatography workflow for researchers and manufacturers. This initiative reflects the growing trend towards digitalization in the industry, as it allows for better data management and operational efficiency. By investing in digital solutions, Merck KGaA is likely to enhance customer engagement and satisfaction, thereby solidifying its market position. As of November current competitive trends are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into chromatography processes. Strategic alliances among companies are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Moving forward, competitive differentiation will likely hinge on the ability to innovate and adapt to changing market dynamics, with a strong emphasis on sustainability and efficiency. ## Recent News & Developments The UK Hydrophobic Interaction Chromatography Market has seen notable developments recently, with companies like Novasep, Repligen Corporation, and Sartorius AG actively enhancing their product offerings to cater to growing demand in biopharmaceutical applications. In September 2023, BioRad Laboratories launched a new line of chromatography columns that improve separation efficiency, notably impacting market dynamics. Furthermore, Thermo Fisher Scientific is expanding its operations in the UK, aiming to strengthen its presence in life sciences and bioprocessing markets. In terms of mergers and acquisitions, GE Healthcare announced in August 2023 its acquisition of a leading chromatography technology firm, further solidifying its market position. Growth in market valuation is evident as significant investments in Research and Development from Merck KGaA and Waters Corporation are fueling innovation and competitiveness. Additionally, the UK government reported in March 2023 that advancements in biopharmaceutical manufacturing processes, which heavily rely on chromatography techniques, are projected to enhance the nation's healthcare system and boost economic growth. Overall, the UK Hydrophobic Interaction Chromatography Market is experiencing robust evolution driven by technological advancements and strategic business activities. ## Report Scope | MARKET SIZE 2024 | 41.79(USD Million) | | --- | --- | | MARKET SIZE 2025 | 45.41(USD Million) | | MARKET SIZE 2035 | 104.32(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.67% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Advancements in biopharmaceuticals drive demand for innovative solutions in the hydrophobic interaction-chromatography market. | | Key Market Dynamics | Growing demand for biopharmaceuticals drives innovation in hydrophobic interaction-chromatography technologies and applications. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current market valuation of the UK hydrophobic interaction-chromatography market?** A: The market valuation was $41.79 Million in 2024. **Q: What is the projected market valuation for the UK hydrophobic interaction-chromatography market by 2035?** A: The projected valuation for 2035 is $104.32 Million. **Q: What is the expected CAGR for the UK hydrophobic interaction-chromatography market during the forecast period 2025 - 2035?** A: The expected CAGR is 8.67% during the forecast period. **Q: Which companies are considered key players in the UK hydrophobic interaction-chromatography market?** A: Key players include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the UK hydrophobic interaction-chromatography market?** A: Main product segments include Resins, Columns, Buffers, and Other Products and Services. **Q: What was the valuation of the Resins segment in the UK hydrophobic interaction-chromatography market in 2024?** A: The Resins segment was valued at $10.0 Million to $25.0 Million in 2024. **Q: How does the Monoclonal Antibodies segment perform in the UK hydrophobic interaction-chromatography market?** A: The Monoclonal Antibodies segment was valued at $15.0 Million to $36.0 Million in 2024. **Q: What is the market performance of the Pharmaceutical & Biopharmaceutical Companies segment?** A: This segment was valued at $16.72 Million to $40.0 Million in 2024. **Q: What is the expected growth trend for the Other Products and Services segment in the UK hydrophobic interaction-chromatography market?** A: The Other Products and Services segment was valued at $6.79 Million to $19.32 Million in 2024. **Q: What types of end-users are involved in the UK hydrophobic interaction-chromatography market?** A: End-users include Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, Contract Manufacturing Organizations, and Research & Academic Institutes. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-hydrophobic-interaction-chromatography-market-56493*